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Abstract Introduction Postpartum depression (PPD) is a
mental health problem frequently experienced by mothers
in the first year postpartum. Early detection and treatment
can help to reduce its negative effect on the development of
the newborn child. Well-baby care (WBC) is a promising
screening setting for early detection of PPD. This system-
atic review investigates the evidence of the effectiveness of
screening for PPD in WBC settings regarding mother and
child outcomes. Methods Three electronic databases were
searched: SCOPUS, PsychINFO and CINAHL. Two
reviewers independently performed the study selection.
Data extraction was based on a predefined data extraction
form. Results Six studies were included; a quality assess-
ment rated two studies as strong and four as weak. Four
studies measuring outcomes at process level showed
improvement in detection, referral and/or treatment rates.
Four studies, including the two strong ones, where
screening and enhanced care were combined, showed
improvements in the Edinburgh Postnatal Depression Scale
scores of the mothers in the intervention groups. No
improvements were reported on other outcomes at parent
level or at child level. At child level, weight was the only
outcome that was measured. Discussion This review pro-
vides limited yet positive evidence for the value of
screening for PPD in a WBC setting. The outcomes are
comparable with studies on screening for PPD in general.
The evidence that we found is very promising but the small
number of available studies shows a need for additional
high-quality studies, to strengthen the evidence regarding
the potential benefits of screening in a WBC setting.
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Significance
What is already known on this subject? Postpartum
depression has a high prevalence and its early detection and
treatment improves the prognosis of both mother and child.
Screening for postpartum depression may be valuable to
improve detection and mother and child outcomes, if
implemented in the right setting.
What this study adds? This review supplies an overview
of the current evidence on the value of screening for PPD
in a well-baby care setting. The evidence found is limited
but promising; it shows that screening in WBC leads to
higher detection, referral and treatment and, when com-
bined with enhanced care, to improvement in lowering
depression scores.
Introduction
Children’s early social-emotional development affects their
mental health during their entire life-course. The parents’
mental health problems can affect this development nega-
tively. One of the most frequent mental health problems
that mothers encounter after delivery is postpartum
depression (PPD). An analysis of 28 prevalence studies
showed that 7.1 % of women suffer from major depression
in the first 3 months postpartum. When minor depression
was included, the prevalence increased to 19.2 % (Gavin
et al. 2005). Children of mothers who had experienced PPD
have more difficulties in their cognitive, social-emotional
and language development, and have higher levels of
internalizing and externalizing behavior, as well as general
psychopathology later in life (Goodman et al. 2011;
Kingston and Tough 2012; Brand and Brennan 2009).
Early treatment of maternal PPD may reduce these prob-
lems (Wan and Green 2009; Sohr-Preston and Scaramella
2006).
Depression can be treated effectively in several ways
(O’Hara and McCabe 2013), but many cases of PPD
remain undetected, partly because mothers face barriers to
discuss their feelings (Liberto 2012) and partly because the
professionals they encounter do not recognize the symp-
toms or fail to discuss them (Heneghan et al. 2000).
Therefore, several articles on PPD advocate incorporation
of screening in public healthcare (Gavin et al. 2005; Lib-
erto 2012). Well-baby care (WBC) may be a very
promising setting for early detection of maternal PPD as
this setting provides routine check-ups during the first year
after delivery (Gjerdingen et al. 2011). The intention of
WBC is to monitor the child’s development and health,
including the wellbeing of the parents. Examples of sys-
tems supplying this care are: the well-child care in the
United States, health visitors in the United Kingdom, Child
and Family Health care in Australia and preventive child
health care systems in various European countries. Systems
providing WBC often have large coverage. In some
countries, WBC is being delivered to 95–99 % of newborn
children (van den Heuvel et al. 2013), thereby also reach-
ing the majority of postpartum mothers.
A few reviews on the efficacy of screening for PPD are
available (Myers et al. 2013; Hewitt et al. 2009), but none
of these specifically address the value of screening in a
WBC setting. We therefore systematically reviewed the
evidence on the effectiveness of screening for PPD in
WBC compared to no screening, regarding mother and
child outcomes and report our findings here according to
the Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) Statement (Liberati et al. 2009).
Methods
Search Method
A search was performed by the first author (A.Z.-B.) in
three electronic databases: Scopus (including all the cita-
tions in PubMed and Embase from 1996), PsychINFO and
CINAHL. We searched the databases for publications up to
May 2014. The search strategies were based on the MESH-
terms (MEDLINE thesaurus) available for the subject and
the key terms extracted from the background literature.
Three main concepts were combined and fed into the
search engine: postpartum depression, early identification,
and well-baby care setting.
As the subject is related to several research areas (psy-
chiatry, child development, primary health care, women‘s
health), we added a number of synonyms for each concept.
We created several alternative terms for the well-baby care
setting as the nature of this kind of setting varies from
country to country. Full details of the search strategy in
Scopus are reported in Appendix 1. We used the same
search strategy for PsychINFO and CINAHL, except for
the exclusion of subject areas as these databases do not
have this option.
Selection Process
Two of the authors, A.Z.-B. and M.B.-B., independently
assessed the eligibility of the resulting publications in three
rounds. The first selection was based on the title. Next, the
abstracts of the selected articles were reviewed according
to the inclusion and exclusion criteria (Table 1), based on
the PICOTS categories (Population, Intervention, Com-
parators, Outcomes, Timing and Setting). In the final
10 Matern Child Health J (2017) 21:9–20
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round, the selected articles were judged after full-text-
reading. Selected articles that appeared to be reviews were
hand searched by one reviewer, A.Z.-B., for additional
references. In each stage of the selection process, the
reviewers used one of three response options to indicate
their opinion as to whether an article should go to the next
stage; ‘‘yes’’, ‘‘no’’, and ‘‘maybe’’. The outcomes of the
two independent reviewers were compared before pro-
ceeding to the next stage. Titles, abstracts and articles with
differing opinions were discussed and reread if necessary.
An independent third reviewer could be consulted to
resolve remaining disagreements, but this proved to be
unnecessary. The author of one article (Yawn et al. 2012)
was contacted to obtain more information on the setting
before deciding on its inclusion.
A flow diagram of the selection procedure is shown in
Fig. 1. Seven articles, concerning six individual studies,
met the inclusion criteria and were used in this review.
Quality Assessment
To assess the quality of the included studies, the reviewers
independently applied the Quality Assessment tool for
Quantitative Studies, developed by the Effective Public
Health Practice Project (EPHPP) (Armijo-Olivo et al.
2012). Studies were rated on six aspects: selection bias,
study design, confounders, blinding, data collection
method, withdrawals and dropouts. The aspects were
explored by answering guiding questions and were next
rated according to established criteria, e.g. for an aspect
Table 1 Inclusion and exclusion criteria
Study
Characteristics
Inclusion Criteria Exclusion Criteria
Population Women up to 12 months postpartum –
Intervention Isolated screening or screening as a part of a more comprehensive
prevention or intervention strategy
Screening for postpartum depression using a validated screening instrument
for depression
Interventions without a screening component
Screening using a non-validated instrument
Comparators Usual care without a screening instruction protocol or without specific
attention for PPD
Screening under different conditions (e.g. setting, timing) or with another
validated instrument
Studies with no control group to compare the
effectiveness of the screening
Outcomes At least one of the following outcomes
Validated diagnostic instruments for depression
Rates of referral for symptoms of depression, rates of positive diagnosis,
and/or implemented treatment
Validated measures of maternal well-being, health-related quality of life,
parenting
Validated measures of child health and development
Maternal and/or child health system resource utilization, including number
of visits and estimates of total and attributable costs
Reported outcomes provide no information on
the effects of the screening
Timing Screening for depression (at least partly) within the first 12 months
postpartum
Screening for depression only during pregnancy
Setting Offering routine contact with a healthcare professional in the first year
postpartum to check the health and development of the child
Serving the general population
Study located in a high-income economic country as defined by the World
Bank
Clinical setting
Setting exclusively addressing the woman and
not the child
Study located in a non- high-income economic
country as defined by the World Bank
Study design Randomized controlled trial
Observational study with comparator (prospective or retrospective)
Sample size C100 subjects
Rcts all sample sizes
Systematic reviews
Nonsystematic review,
Case series, case report, editorial, letter
Report criteria Article in English, Dutch, German or French
Peer-reviewed article
Relevant systematic review, meta-analysis
Article in a language other than English, Dutch,
German or French
No abstract/full text found
Matern Child Health J (2017) 21:9–20 11
123
like data collection methods, rating depended on the
validity and reliability of the data collection tools. A study
received a strong global rating when none of the aspects
were weak, a study with one weak aspect was rated as
moderate, and two or more weak aspects resulted in a weak
global rating. Differences in quality ratings were discussed
and agreement was reached by critically applying the cri-
teria again. In addition to the standard EPHPP scoring,
possible study specific biases were investigated by com-
paring method and result sections on contradictions and
missing data.
Data Synthesis
One reviewer (A.Z.-B.) extracted the data from the six
selected studies using a predefined data extraction form,
including the results of two articles by Glavin et al. (2010)
and Glavin (2012); they were compared but there were no
conflicting or contradicting data. The data categories are
presented in Table 2. The authors of all the included
studies were approached for more information on certain
aspects, like setting or population; three out of six authors
responded and answered our questions. We described the
differences and similarities of the studies in terms of set-
ting, population, the intervention applied including specific
screening aspects like instrument and timing, and the used
outcome measures. After presenting the results of the
quality assessment, a narrative synthesis was undertaken.
The included studies were reviewed for a shared summary
effect measure like risk ratio (RR) or odds ratio (OR),
expressing the effect of screening on primary outcomes
such as an improvement of depression scores. The extrac-
ted data were not pooled or analyzed statistically because
of the small number of studies, the differences in the
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Fig. 1 Flow diagram of study selection
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intervention group
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clinically assessed as
probably depressed in the
control group (C)
• Received treatment:
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13 % of the mothers in I,
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• 12 months: OR for a C5-
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adjusted OR: 1.74 (95 %
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compared interventions, and the heterogeneity of the out-
come measures and time horizons.
Results
Setting and Population
The characteristics of the six included studies are presented
in Table 2. The settings of the studies (Yawn et al. 2012;
Glavin 2012; Glavin et al. 2010; Chaudron et al. 2004;
Leung et al. 2011; Carroll et al. 2013; Gerrard et al. 1993)
differ in location and the professionals performing the
screening. In the studies by Chaudron et al. (2004) and
Carroll et al. (2013), care was delivered by the pediatric
staff from a primary care center. In the Norwegian Glavin
et al. study (2010, 2012), public health nurses screened the
mothers at well-baby clinics, a comparable setting to that
of the Leung et al. (2011) study in Hong Kong, where
nurses screened the mothers at Maternal and Child Health
Centers. The screening investigated by Gerrard et al.
(1993) was carried out by trained health visitors at baby
clinics in England. Yawn et al. (2012) focused on family
medicine research network practices in 21 USA states; 22
of the included practices offered continuity to the mother
and her child, and six only to the mother. Pediatrician
offices offering services only to the child were excluded.
Except for the six practices studied by Yawn et al., the
other practices offered frequent appointments to both
mother and child. In the first year postpartum the frequency
varied from 7 to 10. The intention of the settings was to
service the general population and to reach 90–100 % of
the mothers of newborn children in their area. The fre-
quency and outreach of the services in the Gerrard et al.
study (1993) could not be verified.
Intervention Content
The interventions offered in the various studies differed
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assessment for depression
– JIT-group: the same
reminder as the PSF-









• No questions adapted in
the pre-screening form
























mood: PSF-group: 8.8 %
(OR 7.93, 95 % CI 4.51
to 13.96), JIT-group:
8.7 % (OR 8.10, 95 % CI
4.61–14.25), control
group: 1.2 %
• Registered signs of
anhedonia: PSF-group:
5.1 % (OR 12.58, 95 %
CI 5.03–31.46), JIT-
group: 5.2 % (OR 13.03,
95 % CI 5.21–32.54),
control group: 0.4 %
• Rate of referral: control
group: 1.2 %, PSF-group
and JIT-group: 2.4 %
(OR 2.06, 95 % CI
1.08–3.93)
RCT randomized controlled trial, GP general practitioner, MCHC Maternal and Child Health Center, EPDS Edinburgh Postnatal Depression
Scale, PPD postpartum depression, MCH maternal and child health, PHQ-9 Patient Health Questionnaire, PSF pre-screening form, JIT ‘just in
time‘ handout, PSI Parenting Stress Index, GHQ-12 12-item General Health Questionnaire, CKMSS Chinese Kansas Marital Satisfaction Scale,
DAS-6 Dyad Adult Satisfaction short form, OR odds ratio, CI confidence interval, RR risk ratio
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et al. (2013) studies consisted mainly of incorporating
screening questionnaires into the regular visits. In addition,
Carroll et al. used a decision support system, incorporated
in an electronic medical support system. Depending on the
answers on the screening questionnaire, reminders were
created by the system to guide clinicians during their visit.
Four of the six studies (Yawn et al. 2012; Glavin et al.
2010; Leung et al. 2011; Gerrard et al. 1993) investigated
an intervention consisting of both screening and enhanced
care. In the Glavin et al. study (2010) screening was one of
several components of the intervention and was followed
by a standard supportive counseling session for all mothers
with the Public Health Nurse. Depressed mothers received
follow-up supportive counseling sessions. Yawn et al.
(2012) compared a practice-based training program for
screening, diagnosis, and management of mothers with
PPD. Intervention practices were provided with a set of
tools to facilitate each part of the process. Leung et al.
(2011) also described the steps following screening: par-
ticipants with a positive EPDS were directed to another
nurse for counseling. During this session, subsequent
management was recommended. This could be either non-
directive counseling by a Maternal and Child Health Centre
(MCHC) nurse or referral to the community psychiatric
team. These steps were also offered to mothers clinically
observed as depressed, and were therefore not limited to
the intervention. Mothers with elevated EPDS scores in the
post-training group of the Gerrard et al. study (1993) were
offered 4–8 non-directive counselling visits by their health
visitor.
Screening Instrument, Cut-off Score and Timing
Five studies used the EPDS as the screening instrument; four
(Yawn et al. 2012; Glavin et al. 2010; Chaudron et al. 2004;
Leung et al. 2011) had the same cut-off score ofC10 and one,
by Gerrard et al. (1993), selected 12 as the cut-off score.
Glavin et al. (2010) and Chaudron et al. (2004) mentioned
that clinical judgment should confirm the EPDS indication of
a mother as probably being depressed. Leung et al. (2011)
also considered a positive answer on question ten (suicidal
ideation) as indicative. Carroll et al. (2013) adapted a vali-
dated two question depression screening tool into an existing
pre-screening form. In the study by Yawn et al. (2012),
mothers with an EPDS score ofC10 were asked to complete
the Patient Health Questionnaire (PHQ-9) as well. A mother
was considered to have PPD if her PHQ-9 score wasC10 and
the physician’s evaluation revealed no other cause for the
depressive symptoms. Carroll et al. (2013) reported the
PHQ-9 was added as a hand-out to one of the two interven-
tion arms to assist the physician in diagnosing depression but
no PHQ-9 data were shown in the results. In the studies by
Leung et al. (2011), Glavin et al. (2010) and Yawn et al.
(2012), screeningwas performed once, at 2 months, 6 weeks
and between 5–12 weeks postpartum, respectively. In the
Chaudron et al. study (2004), mothers received the EPDS at
each well-child visit during the child’s first year, starting
with the routine 2 week visit. In the study by Carroll et al.
(2013), mothers were screened every 3 months until the age
of 15 months. Health visitors in the Gerrard et al. study
(1993) were instructed to screen at 6–8 weeks and/or
10–12 weeks, depending on the number of training sessions
attended by the health visitor.
Outcome Measures
The types of primary outcomes depended on the study
design. Studies examining screening without enhanced care
(Chaudron et al. 2004; Carroll et al. 2013) used documented
depressive symptoms and referrals, indicated in Table 2 as
primary outcomes at process level. Five studies (Yawn et al.
2012; Glavin et al. 2010; Chaudron et al. 2004; Leung et al.
2011; Carroll et al. 2013) reported the rates of the elevated
scores on their screening instrument at the moment of
intervention. None of the studies used a golden standard to
confirm the PPD diagnosis. The four studies (Yawn et al.
2012; Glavin et al. 2010; Leung et al. 2011; Gerrard et al.
1993), which examined screening combined with enhanced
care, used the screening instrument of their intervention also
as a primary outcome measure for maternal depressive
symptoms later in the postpartum year. Regarding secondary
outcomes, different outcome measures were used. Three
(Yawn et al. 2012; Glavin et al. 2010; Leung et al. 2011) of
those studies used the Parenting Stress Index (PSI). The only
secondary outcome at child levelwas the child’s bodyweight
at 6 and 18 months presented by Leung et al. (2011).
Study Quality
Table 3 shows the outcomes of the Quality Assessment
tool for Quantitative Studies (Armijo-Olivo et al. 2012).
Four (Glavin et al. 2010; Chaudron et al. 2004; Carroll
et al. 2013; Gerrard et al. 1993) of the six studies were
globally rated as weak, according to this Quality Assessment
tool. All four studies had a weak score on description and
control of possible confounders. In both Chaudron’s
(Chaudron et al. 2004) and Carroll’s (Carroll et al. 2013)
study the data collection methods were weak as their data
were based on health care provider documentations, which
were incomplete and not based on valid instruments in the
control groups.
Interpretation of Results
Four studies presented screening outcomes at process level
(Table 2) (Yawn et al. 2012; Chaudron et al. 2004; Leung
16 Matern Child Health J (2017) 21:9–20
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et al. 2011; Carroll et al. 2013). The effect on the detection
rate when screening for PPD was quantified in three of the
six studies (Chaudron et al. 2004; Leung et al. 2011;
Carroll et al. 2013). The calculated RRs for detection of
PPD in the studies by Chaudron et al. (2004) and Leung
et al. (2011) were, respectively, 5.3 (8.5 %/1.6 %) and 4.8
(29 %/6 %). Improvement in the rate of referral in the
study by Carroll et al. (2013) was presented with an OR of
2.06 (95 % confidence interval (CI) 1.08–3.93). We cal-
culated the RRs for the other three studies: for the referral
to a social worker in the study by Chaudron et al. (2004)
the RR was 18 (3.6/0.2), for receiving treatment in the
study by Leung et al. (2011) the RR was 4.9 (23.8/4.8), and
for being diagnosed as PPD in the study by Yawn et al.
(2012) the RR was 1.6 (66 %/41 %). Carroll et al. (2013)
mentioned that adding handouts to the screening process
resulted in earlier referral, but no data were presented.
Four of the six studies (Yawn et al. 2012; Glavin et al.
2010; Leung et al. 2011; Gerrard et al. 1993) (including the
two strong studies) in which screening and enhanced care
were combined in the intervention, showed significant
improvement of depression scores later in the postpartum
year in the intervention arms. In the Leung et al. study
(2011), mothers in the intervention group had an RR of
0.59 (95 % CI 0.39–0.89) for having an elevated EPDS
(C10) at 6 months postpartum. In the Glavin et al. study
(2010), mothers in the intervention group had an OR of 0.5
(95 % CI 0.3–0.8) for having an elevated EPDS (C10) and
in the Gerrard et al. study (1993) the post-training group
had an RR of 0.51 (9.8 %/19.3 %) for an EPDS of 12 or
above. Mothers in the intervention group in the Yawn et al.
(2012) study had an OR of 1.74 (95 % CI 1.05–2.86) for
having a C5-point drop in PHQ-9 score between baseline
and 12 months postpartum. Of the mothers in the study of
Glavin et al. (2010) who had an EPDS score of 10 or above
at 6 weeks postpartum, those in the intervention group had
a larger improvement in EPDS scores from 6 weeks to
12 months postpartum compared to the those in the control
group (effect size 0.53). We could not create a summarized
effect size as the measurement moments and outcome
measures in the included six studies varied too much.
Regarding secondary outcomes, there were no results on
child development or social-emotional wellbeing. No sig-
nificant difference was found with respect to the child’s
weight in the Leung et al. study (2011). At parent level, no
statistical significant differences were found in secondary
outcomes regarding measuring long-term effects (Table 2),
except in the study by Glavin et al. (2010). The interven-
tion group’s PSI Health subscale 12 months postpartum
demonstrated a better score.
Discussion
This review has identified limited but promising evidence
for the effectiveness of screening for PPD on maternal
health outcomes. Four (Yawn et al. 2012; Chaudron et al.
2004; Leung et al. 2011; Carroll et al. 2013) of the six
studies indicate an increase in detection rate of depressive
symptoms or referral or treatment rates and four studies
report a reduction in depressive symptoms at 3, 6 or
12 months postpartum (Glavin et al. 2010; Leung et al.
2011; Gerrard et al. 1993; Yawn et al. 2012). Screening on
PPD leads to significant changes in the measured secondary
outcomes at mother level in only one study; no relevant
outcomes were measured at child level. Both strong quality
studies were conducted in a setting providing care for both
mother and child, with an intervention consisting of a
combination of screening with some enhancement of care.
It was not possible to untangle the effect of screening from
the offer of extra care.
The improvement in depression scores, and yet the lack
of the effect on secondary outcomes is comparable with
studies on screening for PPD in general. In the HTA-













Selection bias Weak Strong Strong Moderate Strong Strong
Study design Moderate Weak Moderate Strong Strong Strong
Confounders Weak Weak Weak Strong Strong Weak
Blinding Weak Moderate Moderate Moderate Moderate Strong
Data collection
method
Strong Weak Strong Strong Strong Weak
Withdrawals and
dropouts
Weak Not applicable Weak Moderate Moderate Not applicable
Global rating Weak Weak Weak Strong Strong Weak
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review of Hewitt et al. (2009) outcomes were combined.
This resulted in a pooled OR of 0.64 (95 % CI 0.52–0.78)
for scoring above the threshold for depression for women
in an intervention group compared to the control group.
This effect is comparable to those demonstrated by Leung
et al. (2011) and Yawn et al. (2012). The HTA review also
encountered the same problem of disentanglement regard-
ing the effect of screening and enhancement of care, and
the lack of evidence of improving other maternal and child
outcomes. The Agency for Healthcare Research and
Quality (AHRQ) report (Myers et al. 2013) selected some
of the same studies as our review, and also concludes that
screening has a positive effect on depressive symptoms, but
effects on secondary outcomes have not been proven.
The included studies may not have fully exploited the
potentials of screening for PPD in WBC, for several rea-
sons. One aspect is the timing of screening; the potential
benefit of screening in a WBC setting may lie mainly in the
possibility of repeated screening and continuous follow-
ups. However, only three (Chaudron et al. 2004; Carroll
et al. 2013; Gerrard et al. 1993) (weak quality) studies had
repeated screening interventions. Furthermore, mothers in
the control group of other studies (Yawn et al. 2012; Leung
et al. 2011), with high scores on the screening instrument
or suicidal thoughts at the time of intervention, were also
given follow-up advice for ethical reasons. This may have
reduced the effect of the intervention on secondary
outcomes.
Another factor influencing the secondary outcomes may
have been the follow-up-process after screening. Recent
studies (Myers et al. 2013; Yawn et al. 2012) advise to
incorporate follow-up care within the same (primary care)
setting as the screening, which is the case in the two strong
studies (Yawn et al. 2012; Leung et al. 2011). Although
significantly more mothers in the intervention groups were
diagnosed and/or treated, a substantial number of the
depressed women did not receive this follow-up care. As a
consequence, screening might have been less effective.
Finally, most of the included studies used C10 as the EPDS
screening cut-off score. According to Hewitt et al. (2009)
this is the optimal cut point if screening for both major and
minor depression, while 12 is optimal if screening for
major depression only. Use of different cut points may
affect the effectiveness of screening.
Only one study measured the effect of screening for
PPD at child level by including the child’s weight. As the
effect of PPD on the child’s wellbeing is an important
argument in favor of the necessity of screening, we
expected studies examining both screening and enhanced
care to also include some outcomes at child level. Possible
explanations for not including outcomes at child level
might be the limited options for standardization of the
quality of care after screening and for measuring social-
emotional development in the first year after birth. In
addition, controlling the moderators and mediators influ-
encing the social-emotional development is difficult.
Strengths and Limitations
Although many countries have preventive child health care
incorporated in their health care system, nomenclature
proved to be quite diverse. We carefully identified the
different options to ensure we included the most relevant
articles in our search. Another strength of our review is the
thorough systematic search of three extensive databases,
supplemented by systematic hand searches of reviews
included in the search. Every step of the selection process
was consistently executed and judged by two independent
reviewers.
A limitation may be that we did not search the grey
literature for evidence, thus some relevant studies may
have been missed. Reporting bias may have influenced the
outcomes of this review, as the studies included in the
review only reported the positive effect of screening.
Implications
Screening for postpartum depression calls for a setting that
has the facility to combine screening with the judgment of
a professional, reaches most new mothers, has profes-
sionals available who are in a position to create a bond of
trust, and offers frequent contact to the mother in the first
year postpartum. Professional preventive services for child
healthcare can meet all of these criteria, and our current
review supports the potential of screening in WBC with
positive evidence. The small number of studies limits the
precision of the effect estimates.
Future research should aim at creating stronger evidence
of the possible benefits of this combination of character-
istics when screening in a WBC setting. General aspects of
the design and intervention need attention, such as cut-off
scores, golden standards to be used, a control group and the
possibility of separating the effect of screening and sub-
sequent offers of extra care. Moreover, new research
should explore the benefits of repeated screening during the
first year postpartum and, preferably, also include out-
comes at child level.
Conclusions
The evidence in this review on the effectiveness of
screening for PPD in a WBC setting is promising, though
based on a limited number of studies. The use of a vali-
dated instrument like the EPDS led, in all the included
studies, to significantly higher detection of mothers with
18 Matern Child Health J (2017) 21:9–20
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depressive symptoms or, when screening was combined
with enhanced care, to improvement of depression scores.
Whether this leads to better outcomes for mother and child
on the long term needs additional high-quality research.
The potential health gains of screening for PPD in a WBC
setting are large but need to be confirmed.
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Appendix 1: Final Search Terms in SCOPUS,
Listed Per Topic
Postpartum Depression
((TITLE-ABS-KEY(postpartum OR postnatal OR perinatal
OR ‘‘after birth’’ OR puerperal) AND TITLE-ABS-
KEY(depress* OR mood)))
Screening
AND (TITLE-ABS-KEY(screening OR screen OR
screened OR identif* OR ‘‘at risk’’ OR preventi* OR
interven* OR recogni* OR ‘‘depression scale’’ OR tool OR
program* OR strategy))
Well-Baby Care Setting
AND (TITLE-ABS-KEY(pediatr*) OR TITLE-ABS-
KEY(paediatr*) OR TITLE-ABS-KEY(well child) OR
TITLE-ABS-KEY(‘‘well-child’’) OR TITLE-ABS-
KEY(‘‘well baby’’) OR TITLE-ABS-KEY(‘‘well-baby’’)
OR TITLE-ABS-KEY(‘‘youth health care’’) OR TITLE-
ABS-KEY(‘‘child health care’’) OR TITLE-ABS-KEY
(‘‘home visit*’’) OR TITLE-ABS-KEY(‘‘health visit*’’)
OR TITLE-ABS-KEY(‘‘maternal and child health’’) OR
TITLE-ABS-KEY(‘‘maternal child health’’) OR TITLE-
ABS-KEY(‘‘primary care’’) OR TITLE-ABS-KEY(‘‘pri-
mary health care’’) OR TITLE-ABS-KEY(‘‘public health’’)
OR TITLE-ABS-KEY(‘‘community health’’) OR TITLE-
ABS-KEY(‘‘postpartum care’’) OR TITLE-ABS-
KEY(‘‘maternal care’’) OR TITLE-ABS-KEY(‘‘perinatal
care’’) OR TITLE-ABS-KEY(‘‘perinatal health services’’))
Excluded Subject Areas
AND (EXCLUDE(SUBJAREA, ‘‘NEUR’’) OR EXCLU-
DE(SUBJAREA, ‘‘BIOC’’) OR EXCLUDE(SUBJAREA,
‘‘NEUR’’) OR EXCLUDE(SUBJAREA, ‘‘BIOC’’) OR
EXCLUDE(SUBJAREA, ‘‘PHAR’’) OR EXCLUDE
(SUBJAREA, ‘‘AGRI’’) OR EXCLUDE(SUBJAREA,
‘‘ENVI’’) OR EXCLUDE(SUBJAREA, ‘‘IMMU’’) OR
EXCLUDE(SUBJAREA, ‘‘BUSI’’) OR EXCLUDE
(SUBJAREA, ‘‘CENG’’) OR EXCLUDE(SUBJAREA,
‘‘DENT’’))
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